157 related articles for article (PubMed ID: 19655437)
1. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis.
Lin CC; Liang HP; Lee HS; Huang GT; Yang PM; Ho MC; Lee PH; Tsang YM; Chen DS; Sheu JC; Chen CH
J Gastroenterol Hepatol; 2009 May; 24(5):815-20. PubMed ID: 19655437
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.
Kow AW; Kwon CH; Song S; Kim JM; Joh JW
Surgery; 2015 Apr; 157(4):645-53. PubMed ID: 25794626
[TBL] [Abstract][Full Text] [Related]
3. Resection of peritoneal metastases from hepatocellular carcinoma.
Nakayama H; Takayama T; Makuuchi M; Yamasaki S; Kosuge T; Shimada K; Yamamoto J
Hepatogastroenterology; 1999; 46(26):1049-52. PubMed ID: 10370665
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
5. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.
Meier JM; Behr SC; Jordan E; Pallav Kolli K; Yeh BM
Abdom Radiol (NY); 2017 Jun; 42(6):1794-1798. PubMed ID: 28197682
[TBL] [Abstract][Full Text] [Related]
7. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis.
Kwak MS; Lee JH; Yoon JH; Yu SJ; Cho EJ; Jang ES; Kim YJ; Lee HS
Dig Dis Sci; 2012 Mar; 57(3):813-9. PubMed ID: 22147252
[TBL] [Abstract][Full Text] [Related]
8. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal metastasis after emergency hepatectomy and delayed hepatectomy for spontaneous rupture of hepatocellular carcinoma.
Ren A; Luo S; Ji L; Yi X; Liang J; Wang J; Wan S
Asian J Surg; 2019 Feb; 42(2):464-469. PubMed ID: 30420157
[TBL] [Abstract][Full Text] [Related]
11. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
12. Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapy.
Alexandrescu ST; Croitoru AE; Grigorie RT; Tomescu DR; Droc G; Grasu MC; Popescu I
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):28-33. PubMed ID: 32917528
[TBL] [Abstract][Full Text] [Related]
13. Resection of peritoneal metastases in patients with hepatocellular carcinoma.
Hashimoto M; Sasaki K; Moriyama J; Matsuda M; Watanabe G
Surgery; 2013 May; 153(5):727-31. PubMed ID: 22705249
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and survival of patients with hepatocellular carcinoma and cardiac metastasis.
Liu YC; Ho YL; Huang GT; Chen DS; Sheu JC; Chen CH
J Gastroenterol Hepatol; 2010 Jan; 25(1):150-5. PubMed ID: 19929928
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma Peritoneal Metastasis: Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Spiliotis J; Nikolaou G; Kopanakis N; Vassiliadou D; Terra A; Efstathiou E
Gulf J Oncolog; 2017 May; 1(24):20-23. PubMed ID: 28797997
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Li J; Hou Y; Cai XB; Liu B
World J Gastroenterol; 2016 Apr; 22(15):4034-40. PubMed ID: 27099447
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transarterial interventional therapy for treatment of hepatocellular carcinoma with peritoneal metastases.
Duan F; Bai Y; Cui L; Li X; Yan J
J Cancer Res Ther; 2018; 14(7):1563-1566. PubMed ID: 30589039
[TBL] [Abstract][Full Text] [Related]
19. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.
Chen BB; Shih IL; Wu CH; Hsu C; Chen CH; Shih TT; Liu KL; Liang PC
J Vasc Interv Radiol; 2014 Mar; 25(3):371-8. PubMed ID: 24468045
[TBL] [Abstract][Full Text] [Related]
20. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
